Wynn With This Just In
Clinical Articles Brought to You by Lexi-Comp
and Dr. Richard L. Wynn
Click here to subscribe to the Lexi-Comp Dentistry newsletter.
The purpose of this column is to keep professionals
informed of recent reports regarding drugs and other events which may
influence dental treatment. These reports will be gleaned from
scientific journals, screened for dissemination, and presented on a
timely basis and with great accuracy.
It is hoped the dental professional will reap
significant benefit from this information, and it will contribute to
superior patient care.
Each month a new article will be published. If you are
not on our mailing list but would like to receive these newsletters,
please login to the customer center and subscribe through the Campaign
Subscription Center on the left.
View
a list of Dr. Wynn's speaking engagements.
CURRENT
Alpha-Lipoic Acid Useful in Treating Burning Mouth Syndrome
June 2008
PREVIOUS
High Blood Pressure and Underactive Thyroid Gland (Hypothyroidism)
May 2008
Varenicline
(Chantix™) is effective in helping smokers quit, but it is
not without problems.
April 2008
Bisphosphonates
and Dental Implants
March 2008
A
Review of the Harvard Fosamax® Study
February 2008
Fosamax®
and Osteonecrosis of the Jaw – Some New and Frequently Asked
Questions
December 2007
The
Experts Weigh In On Osteonecrosis of the Jaw and Bisphosphonates: A New
Task Force Report
November 2007
New
American Heart Association Guidelines for Preventing Heart Disease in
Women
October 2007
Where
are we with the benefits of aspirin in women?
September 2007
Information
to the Patient from the ADA on the Issues of: (1) The change in
guidelines for antibiotic prophylaxis; (2) Oral bisphosphonates and
osteonecrosis of the jawbone; (3) The stent patient on aspirin and
Plavix®
August 2007
Additional
Treatment Options in the Management of Osteoporosis
July 2007
Osteonecrosis
of the Jaw in Cancer After Treatment with Bisphosphonates: More
Information from Australia
June 2007
New
Guidelines for the Prevention of Infective Endocarditis - the Bottom
Line
May 2007
More
on the Frequency of Oral Bisphosphonate-Associated Osteonecrosis of the
Jaw: A New Report from Australia
April 2007
Nonsteroidal
Anti-Inflammatory Drug Use in the First Trimester of Pregnancy
Increases the Risk of Congenital Anomalies
March 2007
Strong
Advisory Warning Against the Discontinuation of Dual
Aspirin/Clopidogrel (Plavix®) Antiplatelet Therapy in Patients
with Coronary Artery Stents
Feb. 2007
Articaine
(Septocaine®) Formulation with Less Vasoconstrictor Gains FDA
Approval
Jan. 2007
Ibuprofen
Dosing and Naproxen Use in Patients on Cardioprotective Aspirin
Nov 2006
Ibuprofen
Blunts Aspirin's Cardioprotection. FDA Issues Warning
Oct 2006
Johns
Hopkins and the Mayo Clinic Speak to the Issue of
Bisphosphonate-Associated Osteonecrotic Jaw Bone (ONJ)
Sep 2006
More
Findings on the Association Between Bisphosphonates and Osteonecrosis
of the Jaw
Aug 2006
Fosamax,
Boniva and Other Oral Bisphosphonates and Necrotic Jaw Bone
July 2006
Bisphosphonate-associated
osteonecrotic jawbone - continuing with more reports relative to dental
patient management
June 2006
Bisphosphonates,
including alendronate (Fosamax®), and ONJ
May 2006
|
